Skip to content
healthcare.dev

XOLREMDI

NDC 83296-100, mavorixafor, capsule, gelatin coated, from X4 Pharmaceuticals, Inc..

Product NDC
83296-100
Status
Listed
Labeler
X4 Pharmaceuticals, Inc.
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218709
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83296-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MAVORIXAFOR100 mg/1
Package NDCNDC-11Package
83296-100-1283296010012120 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-12)
83296-100-608329601006060 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-60)
83296-100-908329601009090 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f3a5ee3-ca73-4876-85a0-ed1e108a2237

Use it

Look up 83296-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83296-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83296-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.